Attempts were made to target the receptor for CD154, CD40, with anti-CD40 mAbs that have shown promise in treating autoimmune diseases, such as systemic lupus erythematous and inflammatory bowel disease (11, 12). The gene discussed is CD40; the disease is inflammatory bowel disease.